Elena Zamagni

29PUBLICATIONS
168CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Nuclear physicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Jul 30, 2026
Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|Jul 21, 2026
Transition from inpatient to outpatient step-up dosing of bispecific antibodies in multiple myeloma: real-world insights.

|Aug 28, 2025
Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going.

Elena Zamagni, Marco Talarico

|Aug 14, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers 2025, 17, 1168.

Katia Mancuso, Simona Barbato, Francesco Di Raimondo

Pageof 5

Frequent Collaborators

10 joint publications

Katia Mancuso

7 joint publications

Simona Barbato

7 joint publications

Michele Cavo

5 joint publications

Francesca Gay